 |
|
|
 |
|
Men Not Being Told Enough About PSA Tests
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 | 3 Dr. Michael Pignone, an assistant professor of cancer prevention and control at the University of North Carolina at Chapel Hill and author of an accompanying journal editorial, said that "when you total up the potentially beneficial and potential detrimental consequences of PSA screening, it is not clear that the net effect of PSA screening is beneficial."
Pignone noted that the consequences of prostate cancer treatment, such as impotence and incontinence, occur with treatment. "You suffer the down sides right away," he said. "You only get the benefits, in most cases, far into the future."
Pignone noted that even men with prostate cancer are more likely to die from heart disease or dementia than their cancer. Your chance of dying from prostate cancer is one in a 1,000, while the odds of dying from another cause is 113 in 1,000, he said.
Text Continues Below

Brawley noted that the American Cancer Society is reviewing its recommendations for PSA screening, and is expected to change them next year.
"Men should know that there are huge question marks, and for some men who are very concerned, perhaps they should get screened. For some men who are less concerned about prostate cancer, perhaps they should not get screened," Brawley said. "But men should not be told that prostate cancer screening is more beneficial than we have evidence to show."
More information
For more information on prostate cancer, visit the American Cancer Society.
Page: << Prev | 1 | 2 | 3
|
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 9/28/2009
|
 |

SOURCES: Richard M. Hoffman, M.D., M.P.H., New Mexico VA Health Care System, associate professor of medicine, University of New Mexico School of Medicine, Albuquerque; Kirsten Howard, Ph.D., senior lecturer, health economics, University of Sydney, Australia; Michael Pignone, M.D., M.P.H., assistant professor, cancer prevention and control, University of North Carolina, Chapel Hill; Otis W. Brawley, M.D., chief medical officer, American Cancer Society; Sept. 28, 2009, Archives of Internal Medicine
|